|
NCOA2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.119690E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.664200E-03 |
| Normal-vs-Stage2 |
1.657750E-02 |
| Normal-vs-Stage3 |
4.370300E-04 |
| Normal-vs-Stage4 |
1.578010E-03 |
| Stage1-vs-Stage2 |
7.472200E-01 |
| Stage1-vs-Stage3 |
2.518600E-01 |
| Stage1-vs-Stage4 |
3.894200E-01 |
| Stage2-vs-Stage3 |
6.359000E-01 |
| Stage2-vs-Stage4 |
6.822800E-01 |
| Stage3-vs-Stage4 |
9.948000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.799700E-03 |
| Normal-vs-AfricanAmerican |
3.255400E-01 |
| Normal-vs-Asian |
7.823200E-04 |
| Caucasian-vs-AfricanAmerican |
2.865400E-01 |
| Caucasian-vs-Asian |
2.846800E-01 |
| AfricanAmerican-vs-Asian |
8.492100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.91220000000025E-05 |
| Normal-vs-Female |
5.739200E-03 |
| Male-vs-Female |
4.358400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.802140E-02 |
| Normal-vs-Age(41-60Yrs) |
1.278520E-03 |
| Normal-vs-Age(61-80Yrs) |
8.183300E-04 |
| Normal-vs-Age(81-100Yrs) |
1.169990E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.730400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.118200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.245800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.396000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.723000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.197400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.813400E-01 |
| Classical-VS-Follicular |
2.916200E-03 |
| Classical-VS-Other |
6.094100E-02 |
| Classical-VS-Normal |
2.272400E-02 |
| Tall-VS-Follicular |
4.049000E-01 |
| Tall-VS-Other |
1.357650E-01 |
| Tall-VS-Normal |
6.756800E-03 |
| Follicular-VS-Other |
3.453000E-01 |
| Follicular-VS-Normal |
2.27709999999215E-05 |
| Other-VS-Normal |
3.343200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.766000E-04 |
| Normal-vs-N1 |
1.482590E-03 |
| N0-vs-N1 |
6.424600E-01 |
|
|
